Clofarabine and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Clofarabine (clofarabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cytarabine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Weakness when taking Clofarabine. It is created by eHealthMe based on reports of 2,637 people who have side effects when taking Clofarabine from the FDA, and is updated regularly.

What is Clofarabine?

Clofarabine has active ingredients of clofarabine. eHealthMe is studying from 2,644 Clofarabine users. Check the latest studies of Clofarabine.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

2,637 people reported to have side effects when taking Clofarabine.
Among them, 49 people (1.86%) have Weakness.

Among these 49 people:

How long have people been on Clofarabine when they have Weakness? *

What is the gender of people who have Weakness when taking Clofarabine? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Weakness when taking Clofarabine? *

What are other drugs people take besides Clofarabine? *

What are other side effects people have besides Weakness? *

Diarrhea: 13 people, 26.53%
Hypotension (abnormally low blood pressure): 12 people, 24.49%
Acute Kidney Failure: 11 people, 22.45%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 18.37%
Multi-Organ Failure (multisystem organ failure): 9 people, 18.37%
Headache (pain in head): 8 people, 16.33%
Pneumonia: 8 people, 16.33%
Anaemia (lack of blood): 8 people, 16.33%
Blood Creatinine Increased: 7 people, 14.29%
Fatigue (feeling of tiredness): 7 people, 14.29%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 34.69%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 10.20%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 10.20%
Bone Marrow Conditioning Regimen: 5 people, 10.20%
Acute Leukaemia (blood cancer): 3 people, 6.12%
Nausea (feeling of having an urge to vomit): 3 people, 6.12%
Fever: 2 people, 4.08%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 2 people, 4.08%
Immunodeficiency Disorders: 2 people, 4.08%
Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Do you take Clofarabine and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clofarabine:

Clofarabine (2,644 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Clofarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clofarabine (the active ingredients of Clofarabine) and Clofarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.